Results 1 to 10 of about 126,514 (307)
Nature Reviews Disease Primers, 2022 Osteosarcoma is the most common primary malignant tumour of the bone. Osteosarcoma incidence is bimodal, peaking at 18 and 60 years of age, and is slightly more common in males.
Janeway, Katherine +9 more
core +9 more sources
, 2009 Studies to determine the etiology of osteosarcoma involve epidemiologic and environmental factors and genetic impairments. Factors related to patient characteristics include age, gender, ethnicity, growth and height, genetic and familial factors, and ...
Giulia Ottaviani +3 more
core +3 more sources
The epidemiology of osteosarcoma
, 2009 Osteosarcoma derives from primitive bone-forming mesenchymal cells and is the most common primary bone malignancy. The incidence rates and 95% confidence intervals of osteosarcoma for all races and both sexes are 4.0 (3.5-4.6) for the range 0-14 years ...
Giulia Ottaviani +3 more
core +4 more sources
Negative CT Contrast Agents for the Diagnosis of Malignant Osteosarcoma
Advanced Science, 2019 The current positive computed tomography (CT) contrast agents (PCTCAs) including clinical iodides, present high CT density value (CT‐DV). However, they are incapable for the accurate diagnosis of some diseases with high CT‐DV, such as osteosarcoma ...
Xianfu Meng, Baoming Wang, Yanyan Liu
exaly +2 more sources
Osteosarcoma of Jaw Masquerading as Calcifying Epithelial Odontogenic Tumour- A Diagnostic Dilemma [PDF]
Journal of Clinical and Diagnostic Research, 2022 Osteogenic osteosarcoma is the most widely recognised primary malignant bone tumour involving particularly the appendicular skeleton. Osteosarcoma of jaw including maxillary and mandibular osteosarcoma accounts for about 7% of cases.
Neha Sethi +4 more
doaj +1 more source
Acta Pharmaceutica Sinica B, 2022 Osteosarcoma is a kind of bone tumor with highly proliferative and invasive properties, a high incidence of pulmonary metastasis and a poor prognosis. Chemotherapy is the mainstay of treatment for osteosarcoma.
Geni Ye +12 more
doaj +1 more source
Frontiers in Oncology, 2022 Osteosarcoma is one of the bone malignancies in children and adolescents. Long noncoding RNAs (lncRNAs) have been demonstrated to participate in osteosarcoma development and progression.
Ting Chen +4 more
doaj +1 more source
The bioinformatic approach identifies PARM1 as a new potential prognostic factor in osteosarcoma
Frontiers in Oncology, 2023 ObjectiveTo explore the key factors affecting the prognosis of osteosarcoma patients.MethodsBased on the GEO dataset and differential expression analysis of normal and osteosarcoma tissues, the gene modules related to the prognosis of osteosarcoma ...
Haijun Feng +3 more
doaj +1 more source
Annals of Oncology, 2010 The successful treatment of patients with osteosarcoma requires close cooperation within an experienced multidisciplinary team including pediatric or medical oncologists, surgeons, pathologists and radiologists. Therefore, therapy should be performed in specialized centers able to provide access to the full spectrum of care.
J, Ritter, S S, Bielack
openaire +4 more sources
Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma
Frontiers in Oncology, 2021 Osteosarcoma is a major malignant tumor of bone and soft tissue, which is presenting with early metastasis and a high mortality rate. Platelet activating factor acetylhydrolase 1B3 (PAFAH1B3), a cancer-relevant molecular, was found to play a vital role ...
Jian Fan +7 more
doaj +1 more source